Lynn Wester
Promovendus / gast
- Naam
- L. Wester MSc
- Telefoon
- +31 71 527 2727
- l.wester@lacdr.leidenuniv.nl
Promovendus / gast
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Toxicology
- Wester L., Venneker S., Hazenoot M., Pont C.M., Koedoot E., Timmermans A.M., Martens J.W.M., Jansen M.P.H.M., Kockx C.E.M., IJcken W.F.J. van, Meerman J.H.N., Zhang Y. & Water B. van de (2022), A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer, Biochemical Pharmacology 204: 115233.
- Zhang Y., Wester L., He J., Geiger T., Moerkens M., Siddappa R., Helmijr J.A., Timmermans M.M., Look M.P., Deurzen C.H.M. van, Martens J.W.M., Pont C.M., Graauw M. de, Danen E.H.J., Berns E.M.J.J., Jansen M.P.H.M., Meerman J.H.N. & Water B. van de (2018), IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer, Oncogene 37(14): 1869-1884.
- Moerkens M., Zhang Y., Wester L., Water B. van de & Meerman J.H.N. (2014), Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation, BMC Cancer 14: 283.